Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Prof. Zeng Qingjun | Gastrointestinal Tumors | Best Researcher Award

Yueyang Central Hospital | China

AUTHOR PROFILE

ORCID ID

📚EARLY ACADEMIC PURSUITS 

ZENG QINGJUN completed his Master’s degree at Xiangya Medical College, Central South University, in 2010. This prestigious institution provided a strong foundation in medical education, equipping him with the skills and knowledge necessary for his future in the field of gastrointestinal surgery. His academic training allowed him to develop expertise in complex surgical techniques, laying the groundwork for his career as a clinical specialist in surgery.

⚕️PROFESSIONAL ENDEAVORS 

Since July 2010, ZENG QINGJUN has been working in the field of gastrointestinal surgery, focusing on laparoscopic techniques for treating gastric and colorectal cancers. As a chief physician, he plays a pivotal role in leading surgical teams, performing high-risk surgeries, and making critical decisions for patient care. His clinical expertise and skillful handling of over 200 laparoscopic gastric cancer surgeries and 400 laparoscopic colorectal cancer surgeries are testaments to his proficiency in minimally invasive surgical methods. His surgical outcomes have contributed significantly to improving the quality of life for cancer patients and are recognized within the medical community.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON GASTROINTESTINAL TUMORS

Dr. ZENG has dedicated much of his professional life to the development and refinement of laparoscopic surgical techniques in the treatment of gastrointestinal cancers. His research is heavily focused on advancing minimally invasive surgery, particularly in the areas of gastric cancer and colorectal cancer. Through clinical trials and innovative methodologies, he has been involved in optimizing surgical procedures to ensure better postoperative recovery, reduced complications, and more efficient treatment pathways for cancer patients.

🌍IMPACT AND INFLUENCE 

Dr. ZENG QINGJUN has made an immense impact on the practice of gastrointestinal surgery in China, particularly in the realm of laparoscopic surgery. His innovative approaches and commitment to cutting-edge techniques have influenced both local and national surgical practices. His contribution to gastric and colorectal cancer surgery has improved patient outcomes and has set new standards in the field. As a chief physician, he mentors younger surgeons and shares his expertise, ensuring the continued progress of surgical techniques.

📑ACADEMIC CITATIONS 

While detailed citation metrics are not provided, Dr. ZENG’s extensive clinical experience and research endeavors have led to his recognition in academic circles. His focus on laparoscopic techniques and cancer surgery continues to influence current and future generations of surgeons and researchers in the field. His work, particularly in gastric and colorectal cancer, has made notable contributions to medical literature and has been referenced in various academic and clinical studies.

🌱LEGACY AND FUTURE CONTRIBUTIONS 

Dr. ZENG QINGJUN’s career reflects a legacy of excellence in surgical practice and medical innovation. His pioneering work in laparoscopic surgery and cancer treatment has already set the stage for future breakthroughs in the field of gastrointestinal oncology. Looking forward, he is likely to contribute even more significantly to surgical research, possibly expanding his focus to robot-assisted surgeries, postoperative care advancements, and the integration of AI in surgical planning. His mentorship, both locally and nationally, will shape the future of surgical education and the next generation of gastrointestinal surgeons.

💼LEADERSHIP IN SURGICAL PRACTICE 

Dr. ZENG continues to hold a significant leadership role in the surgical department at his medical institution. His capacity as chief physician enables him to make high-level decisions in clinical practice, direct surgical teams, and implement best practice guidelines. His strategic leadership in gastrointestinal surgery helps to establish protocols for laparoscopic surgeries, improving surgical outcomes, and pushing the boundaries of traditional approaches.

🔗 CONCLUSION

Dr. Zeng Qingjun is a distinguished gastrointestinal surgeon whose work has significantly advanced the field of laparoscopic surgery for gastric and colorectal cancers. With over a decade of experience and hundreds of successful surgeries, his contributions have set new standards in minimally invasive surgical techniques, improving patient outcomes and recovery times. Through his leadership as chief physician, he has not only influenced clinical practices but has also become a mentor to aspiring surgeons, ensuring the continuity of high-quality surgical education.

📊🔬NOTABLE PUBLICATION:
  • 1. Title: Knockdown of BUB1B Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer by Regulating the JNK/c-Jun Signaling Pathway
    Authors: Qingjun Zeng, Sanjun Zhang, Linfang He, Qingyan Fu, Li Liao, Linjie Chen, Xiang Ding
    Journal: Cancer Biotherapy and Radiopharmaceuticals
    Year: 2023


    2. Title: Targeting of MAD2L1 by miR‐515‐5p involves the regulation of cell cycle arrest and apoptosis of colorectal cancer cells
    Authors: Xiang Ding, Qingyan Fu, Weixing Chen, Linjie Chen, Qingjun Zeng, Sanjun Zhang, Linfang He
    Journal: Cell Biology International
    Year: 2022

Mr. Tianhao Zou | Cancer Immunotherapy | Best Researcher Award

Mr. Tianhao Zou | Cancer Immunotherapy | Best Researcher Award

Tongji Medical College Huazhong University of Science and Technology | China

Author Profile

Scopus

🌟Dr. Tianhao Zou: A Rising Star in Hepatobiliary Oncology 🌟

Full Name: Tianhao Zou
Gender: Male
Designation: Resident Physician
Department: Department of Hepatobiliary Surgery, Center for Liver Transplantation
Institution/Organization: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
Qualification: Doctor
Area of Specialization: Hepatobiliary Oncology and Cancer
Sub Division: Oncology Therapeutics and Novel Approaches
DOB: September 10, 1997
DOJ: July 01, 2021
Total Experience: Doctor for 1 year, Master for 3 years, Bachelor for 5 years
Mobile Number: +86 18162279089
Email: zoutianhao@126.co

📚 Education:

  • 2015-2020: Bachelor of Clinical Medicine, School of Medicine of Nanchang University.
  • 2020-2023: Master of Surgery, Tongji Medical College, Huazhong University of Science and Technology.
  • 2023-present: Doctor of Surgery, Tongji Medical College, Huazhong University of Science and Technology.

🔬 Experience:

  • July 2021 to present: Resident Physician, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology.

🏅 Research, Innovations, and Extensions:

  • No. of Research Projects Completed and Ongoing: 6
  • Citation Index: 61
  • Consultancy and Industry Sponsored Projects: 0
  • Books Published with ISBN: 0
  • Total Cost of Projects: $414,000 USD
  • Patents Published and Under Process: 5
  • Journals Published in SCI and SCIE Index: 12
  • Editorial Appointments in Journals/Conferences: 2
  • Journals Published in Scopus, Web of Science, and PubMed Index: 13
  • Countries Visited for Research Activities: 1
  • Journals Published in Other Index: 4
  • Research Scholars Graduated: 0
  • Conference Presentations: 0
  • Research Scholars Ongoing: 0
  • Cumulative Impact Factor (Last 3 Years): 55
  • Invited Speaker/Resource Person: 1
  • H-index: 5
  • Research Conferences/Workshops Organized: 0
  • Collaborative Activities for Research: 0
  • Awards and Recognition Received: 1
  • Functional MoUs with Other Universities/Industries/Corporates: 0
  • Membership in Professional Bodies: 10

🌟 Areas of Research:

  • Oncology Therapeutics and Novel Approaches

Contributions to Research & Development, Innovations, and Extension Activities:

Dr. Tianhao Zou has made substantial contributions to the field of tumor research, particularly focusing on hepatobiliary malignancies. His active participation in research projects has significantly advanced the understanding of tumor biology, therapeutic interventions, and patient care outcomes. By collaborating with interdisciplinary teams, Dr. Zou has identified novel biomarkers, therapeutic targets, and treatment modalities aimed at improving patient outcomes and quality of life.

In his innovative efforts, Dr. Zou has played a pivotal role in translating research findings into clinical practice. His collaborations with industry stakeholders, academic institutions, and healthcare providers have facilitated the development and implementation of cutting-edge technologies and treatment approaches in oncology.

Beyond his research endeavors, Dr. Zou is committed to extension activities that promote cancer prevention, early detection, and treatment within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with essential information and resources to combat cancer effectively. Dr. Zou’s dedication to advancing cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.

🔗 Proof Links:

Institute ID: D202382031
Certificate (Education Proof of Last Degree): 1048732023102672
Passport/Govt. ID (Age Proof): 360425199709100212

🎖️Suitable Award Categories:

  • Distinguished Scientist Award
  • Young Scientist Award
  • Lifetime Achievement Award
  • Outstanding Scientist Award
  • Women Research Award
  • Best Researcher Award
  • Best Innovation Award
  • Best Faculty Award
  • Best Research Scholar Award
  • Excellence in Innovation
  • Excellence in Research
  • Excellence Award (Any Scientific Field)
  • Best Research/Innovation Extension Activity

📜✍️Declaration:

I authenticate that to the best of my knowledge, the information given in this form is correct and complete. At any time I am found to have concealed any material information, my application shall be liable to be summarily terminated without notice. I have read the terms and conditions and other policies of the International Research Awards and agree to stand by the same. I agree to Pencis to process the data submitted in this application form, or any other data that the Foundation may obtain from me for any purposes connected with Pencis for any other legitimate reason.

📊🔬Notable Publication:

 

 

  • Title: Cell therapy for neuropathic pain
    • Authors: Yin, Q.; Zou, T.; Sun, S.; Yang, D.
    • Journal: Frontiers in Molecular Neuroscience
    • Volume: 16
    • Pages: 1119223
    • Year: 2023

 

 

Ms. Hao Li – Tumor Immunology – Young Scientist Award

Ms. Hao Li - Tumor Immunology - Young Scientist Award

First Hospital of China Medical University - China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Li Hao began his academic journey at Dalian Medical University in September 2015, majoring in Immunology, Biochemistry, Surgery, and Internal Medicine. During this period from 2015 to 2020, he laid the foundational knowledge in the medical sciences that would serve as the basis for his future specialization. His undergraduate studies provided him with a comprehensive understanding of the human body's immune system, biochemistry, surgical techniques, and internal medicine.Li Hao pursued his Master's degree in Emergency Medicine and Molecular Biology at China Medical University. This advanced academic pursuit enabled him to delve deeper into specialized areas of medicine, focusing on emergency care and the molecular mechanisms underlying various medical conditions.

PROFESSIONAL ENDEAVORS

In May 2021, Li Hao started his professional career as a Resident Physician at the First Hospital of China Medical University. During his tenure from May 2021 to August 2021, he gained hands-on experience in clinical settings, honing his skills in medical records writing and cardiopulmonary resuscitation (CPR). This role allowed him to apply his theoretical knowledge from his undergraduate studies in a practical setting, preparing him for more specialized roles in the medical field.In June 2023, Li Hao transitioned to the role of an Assistant at the First Hospital of China Medical University, where he continues to work to the present day. As an Assistant, he has been involved in research projects and clinical work, further expanding his expertise and contributing to advancements in the medical field.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Li Hao's research interests are diverse and interdisciplinary, focusing on the areas of nanomaterials, hepatocellular carcinoma, and macrophage biology. His research aims to explore innovative approaches and treatments for these medical conditions, leveraging the latest advancements in molecular biology and emergency medicine.

IMPACT AND INFLUENCE

Li Hao's contributions to the medical field extend beyond his professional roles, as he actively engages in research and academic pursuits that have the potential to make a significant impact. His research in nanomaterials, hepatocellular carcinoma, and macrophage biology could lead to breakthroughs in treatment options and improve patient outcomes in these areas.

ACADEMIC SITES

Li Hao's academic achievements and research contributions have likely been cited in various scientific publications and conferences. His interdisciplinary research in nanomaterials, hepatocellular carcinoma, and macrophage biology demonstrates his commitment to advancing medical science and contributing valuable insights to the academic community.

LEGACY AND FUTURE CONTRIBUTIONS

As Li Hao continues to pursue his career in emergency medicine and molecular biology, his interdisciplinary research and clinical experience will undoubtedly leave a lasting legacy in the medical field. His dedication to improving patient care and advancing medical science positions him as a promising young professional with the potential to make significant contributions to the future of healthcare.

NOTABLE PUBLICATIONS

Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors.  2024

Glutamate Chemical Exchange Saturation Transfer (GluCEST) MRI to Evaluate the Rapid Antidepressant Effects of Ketamine in the Hippocampus of Rat Depression Model. 2024 (1)

Preclinical multi-physiologic monitoring of immediate-early responses to diverse treatment strategies in breast cancer by optoacoustic imaging. 2024

Glutamate alterations in the premature infant brain during different gestational ages with glutamate chemical exchange saturation transfer imaging: a pilot study. 2023 (1)

Xenon inhalation attenuates neuronal injury and prevents epilepsy in febrile seizure Sprague-Dawley pups. 2023 (1)